Home > Insider Trading > Filing (0001104659-24-036346)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819576	Liquidia Corp	LQDA	Pharmaceutical Preparations (2834)	851710962

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1935638	Rajeev Saggar	419 Davis Drive, Suite 100 Morrisville NC 27560	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-18	1,654	$15.82	220,722	No	4	S	Direct
Common Stock	Disposition	2024-03-18	5,876	$15.82	214,846	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 28, 2022.
These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023.
Includes (i) 40,638 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 62,499 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 3,604 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.